Collegium Pharma Inc. (coll 2.875 02/15/29)
13F holders, Q1 2026 (March 31)1holders −1
1new positions
2sold out
$1.16avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Collegium Pharma Inc. (coll 2.875 02/15/29) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 2 sold out. The largest holder was Ssi Investment Management LLC ($5.9M).
- Company
- Collegium Pharma Inc. (coll 2.875 02/15/29)
- CUSIP
- 19459JAC8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5.9M |
| Exits | 2 | $16.4M |
All 13F filers, Q4 2025 → Q1 2026: 5,100,000 shares bought and 4,007,500 shares sold, net +1,092,500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ssi Investment Management LLC | 0.49% | New | 5,100,000 | $5.9M |
"% of holder's portfolio" is COLLEGIUM PHARMA INC (COLL 2.875 02/15/29)'s weight in each manager's 13F, not the share of Collegium Pharma Inc. (coll 2.875 02/15/29) the manager owns.